Statement from FDA on continuing efforts to maintain its strong oversight of generic drugs
date:Feb 25, 2019
ensuring that high quality products reach U.S. patients. The FDAs role is to provide sufficient oversight through application reviews and inspections to ensure that companies fulfill their responsibilities and to take appropriate action when they do not. In addition to our pre-market steps, this oversight also includes testing selected finished drug products and APIs after theyre on the market. This testing affirms that the potency, quality, and consistency of generic medicines meets the stand
31/35 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/17 08:39